/ Not yet recruitingPhase 2 A Double-blinded, Parallel-group, Randomized, Active-controlled Phase 2 Clinical Trial to Assess the Safety, Tolerability, Efficacy, and Pharmacokinetics of Intravenous HY-001 Versus Standard Colistin Methanesulfonate Sodium Monotherapy in Patients with Complicated Urinary Tract Infection (with or without pyelonephritis) or Acute Uncomplicated Pyelonephritis at Risk for Infection with Multidrug Resistant Gram-negative Pathogens.
100 Clinical Results associated with Helperby Therapeutics Ireland Ltd.
0 Patents (Medical) associated with Helperby Therapeutics Ireland Ltd.
100 Deals associated with Helperby Therapeutics Ireland Ltd.
100 Translational Medicine associated with Helperby Therapeutics Ireland Ltd.